Research and Development

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …

A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …

A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …

A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …